© 2021 Evolve Business Intelligence. All rights reserved. Developed by Nectron
compounding chemotherapy Industry
Compounding Chemotherapy Market Analysis and Forecast (2021-2028) with COVID Impact Analysis
€ 3,076.07Compounding Chemotherapy Market By Compounding Type (Pharmaceutical Ingredient Alteration (PIA), Currently Unavailable Pharmaceutical Manufacturing (CUPM), Pharmaceutical Dosage Alteration (PDA])), By Technology (With Robotic Arms, Without Robotic Arms), By Dose (Chemotherapeutic, Non-Chemotherapeutics), By Delivery Method (Gravimetric Automated Compounding Device (weight-based), Volumetric Automated Compounding Device (volume-based)) and By Geography – COVID-19 Impact Analysis, Post COVID Analysis, Opportunities, Trends and Forecast from 2021 to 2028
Report Code: EB_LS_1071 | Page: 106 | Published Date: May 2021